Physician profile
Mark Stripling
NPI 1073575148
$1,470.43
in general payments reported to CMS, 2019-2025
21 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.02 · 2021: $24.60 · 2022: $273 · 2023: $360 · 2024: $415 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $265.24 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $211.45 | 2022-2025 | |
| Abbvie INC. | $183.67 | 2019-2024 | Qulipta |
| Exeltis, USA INC. | $167.24 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $118.27 | 2022-2024 | |
| Biogen, INC. | $86.92 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $75.63 | 2022-2023 | Omni Hysteroscope, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Medtronic, INC. | $72.07 | 2022-2024 | Ligasure |
| Davol INC. | $44.72 | 2024 | Arista Ah Flexitip |
| Shield Therapeutics INC | $42.75 | 2024 | |
| Organon LLC | $31.04 | 2025 | Jada System |
| Sumitomo Pharma America, INC. | $29.42 | 2024-2025 | Myfembree |
| Lsi Solutions INC | $19.29 | 2023 | Fornisee |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.60 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.74 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.56 | 2024 | Gardasil, Gardasil 9 |
| Pfizer INC. | $15.40 | 2025 | |
| Therapeuticsmd, INC. | $15.00 | 2022 | |
| Amgen INC. | $14.91 | 2024 | Evenity, Prolia |
| Millicent US INC | $14.49 | 2025 | Femlyv, Intrarosa |
| Smith+Nephew, INC. | $14.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Stripling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.